MetaCap

Who Owns Palisade Bio Stock?

NASDAQ: PALIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.8399-0.0855 (-9.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
100.50%
Institutional holders
150
  • Institutions 95.5%
  • Insiders 4.5%
  • Public and other 0.0%

Who owns Palisade Bio stock?

Institutional investors own about 100.5% of Palisade Bio's shares, spread across 150 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.48% of PALI.

The largest institutional holders are Soleus Capital Management, L.P. (8.36%), Ameriprise Financial, Inc. (8.13%) and B Group, Inc. (6.37%). Together, the top 10 institutions control 57.2% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their PALI positions and 0 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of PALI

Palisade Bio top institutional holders
InstitutionShares% HeldChange
Soleus Capital Management, L.P.15.00M8.36%+14.8%
Ameriprise Financial, Inc.14.57M8.13%+31.5%
B Group, Inc. 11.41M6.37%0.0%
Blackrock Inc.11.10M6.19%+6.3%
Janus Henderson Group Ltd.10.69M5.96%0.0%
Octagon Capital Advisors LP10.28M5.73%0.0%
Perceptive Advisors Llc8.43M4.70%0.0%
Vanguard Capital Management LLC7.89M4.40%+357.9%
RA Capital Management, L.P.7.12M3.97%0.0%
Franklin Templeton, Inc.6.07M3.39%+4.9%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of PALI

Palisade Bio top fund holders
FundShares% Held
iShares Trust-iShares Russell 2000 ETF4.03M2.25%
Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund3.14M1.75%
Franklin Strategic Series-Franklin Biotechnology Discovery Fund2.12M1.18%
abrdn Life Sciences Investors1.91M1.07%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.72M0.96%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.62M0.90%
iShares Trust-iShares Russell 2000 Value ETF1.12M0.63%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund843.88K0.47%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund787.55K0.44%
TIAA-CREF Funds-Nuveen Equity Index Fund773.20K0.43%

Frequently asked questions

Who is the largest shareholder of Palisade Bio?

Soleus Capital Management, L.P. is the largest institutional shareholder of PALI, owning 8.36% of shares outstanding (15.00M shares) as of its latest 13F filing.

What percentage of Palisade Bio is owned by institutions?

Institutions own about 100.5% of PALI shares and 105.2% of the public float.

How much of Palisade Bio do insiders own?

Insiders, such as officers and directors, own about 4.48% of PALI shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related